A vaccine for the coronavirus will likely be ready by early 2021 but rolling it out safely across India’s 1.3 billion people will be the country’s biggest challenge in fighting its surging epidemic, a leading vaccine scientist told Bloomberg.
The country, which is host to some of the front-runner vaccine clinical trials, currently has no local infrastructure in place to go beyond immunising babies and pregnant women, said Gagandeep Kang, professor of microbiology at the Vellore-based Christian Medical College and a member of the WHO’s Global Advisory Committee on Vaccine Safety.
The timing of the vaccine is a contentious subject around the world. In the US, President Donald Trump has contradicted a top administration health expert by saying a vaccine would be available by October. Prime Minister Narendra Modi’s government had promised an indigenous vaccine as early as mid-August, a claim the government and its top medical research body has since walked back.
For a country of its size, and with a virus curve that shows no sign of flattening, a safe and quick vaccine is a top priority for the PM Modi’s administration. The country’s broken health-care system, already struggling to deliver adequate care before the outbreak, cannot cope with the strain of a prolonged pandemic. A strict lockdown implemented in late March led to the biggest contraction among major economies with gross domestic product shrinking 23.9% in the three months to June from a year earlier.
“By year-end we will have data that will tell us which vaccines are working and which ones are not going to do so well,” said Ms Kang, who until July was heading the government committee looking into prospective indigenous vaccine candidates. “If we get good results by year-end then we are looking at vaccines being potentially available in tiny numbers in first half of 2021 and larger numbers in the latter part.”
Ms Kang said that any vaccine currently in phase three trials, whether locally made or being tested by major western pharmaceutical companies, had a 50% chance of success.
India is hosting clinical trials for all the major vaccine contenders. Serum Institute of India, the world’s largest vaccine manufacturer, is conducting trials for the vaccine developed by Oxford University. The drugmaker Dr Reddy’s Laboratories said last week it will distribute the Russian vaccine after conducting final-stage human trials and receiving regulatory approval.
Indigenous vaccine developers Bharat Biotech International Ltd are at the second-phase human trial stage and Zydus Cadila is in the process to receive approvals for conducting third-phase clinical trials.
Even after an effective vaccine is available, India will be staring at storage and delivery barriers as the outbreak escalates through the nation’s hinterland. The world’s second most populous country also has no experience of, and infrastructure for, mass immunisation across age groups.
“We have no life cycle immunisation structures, we have no way of vaccinating the elderly who are a particular risk group here,” said Ms Kang. “Just building the system to be able to immunise all ages is going to be a challenge.”
Even as the nation races to get access to a reliable vaccine to control its fast moving pandemic, its patchy testing strategy may end up underestimating the true extent of its outbreak.
India has been relying increasingly on quick antigen tests that can report false negatives as much as 50% of the time and its daily testing data doesn’t specify what type of tests — antigen or the more sensitive real time-polymerase chain reaction tests — make up the total or whether they were conducted on symptomatic or asymptomatic people, said Ms Kang.
- Stressing freedom, vaccine opponents rebranding in virus era - October 22, 2020
- India's First Transparent NT Mask from Comofi Medtech Makes Communication & COVID-19 Swab Collection Easier - October 22, 2020
- Create the Ideal Game Day Gathering Space - October 22, 2020
- Can Ulcerative Colitis Be Cured With Surgery? - October 22, 2020
- Germany reports record new virus cases in 24 hours - October 22, 2020
- Students Join Hands To Carry Former Teacher Across The Finish Line - October 22, 2020
- Introducing SpotOn Virtual Smart Fence – The First and Only Mobile Dog Containment and Tracking System - October 22, 2020
- Could Running Actually Be Good For Your Knees, What Do Researches Claim? - October 22, 2020
- How fear encourages physical distancing during pandemic - October 22, 2020
- Zebra Introduces Flagship MC9300 Mobile Computer Ideal for On-Demand Economy - October 22, 2020